• Je něco špatně v tomto záznamu ?

Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action

E. Havránková, J. Csöllei, D. Vullo, V. Garaj, P. Pazdera, CT. Supuran,

. 2018 ; 77 (-) : 25-37. [pub] 20180103

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012920

A new series of s-triazine derivatives incorporating sulfanilamide, homosulfanilamide, 4-aminoethyl-benzenesulfonamide and piperazine or aminoalcohol structural motifs is reported. Molecular docking was exploited to select compounds from virtual combinatorial library for synthesis and subsequent biological evaluation. The compounds were prepared by using step by step nucleophilic substitution of chlorine atoms from cyanuric chloride (2,4,6-trichloro-1,3,5-triazine). The compounds were tested as inhibitors of physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isoforms. Specifically, against the cytosolic hCA I, II and tumor-associated hCA IX. These compounds show appreciable inhibition. hCA I was inhibited with KIs in the range of 8.5-2679.1 nM, hCA II with KIs in the range of 4.8-380.5 nM and hCA IX with KIs in the range of 0.4-307.7 nM. As other similar derivatives, some of the compounds showed good or excellent selectivity ratios for inhibiting hCA IX over hCA II, of 3.5-18.5. 4-[({4-Chloro-6-[(4-hydroxyphenyl)amino]-1,3,5-triazin-2-yl}amino)methyl] benzene sulfonamide demonstrated subnanomolar affinity for hCA IX (0.4 nM) and selectivity (18.50) over the cytosolic isoforms. This series of compounds may be of interest for the development of new, unconventional anticancer drugs targeting hypoxia-induced CA isoforms such as CA IX.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012920
003      
CZ-PrNML
005      
20190409163055.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bioorg.2017.12.034 $2 doi
035    __
$a (PubMed)29324250
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Havránková, Eva $u University of Veterinary and Pharmaceutical Sciences, Faculty of Pharmacy, Department of Chemical Drugs, Palackého 1-3, CZ-612 42 Brno, Czech Republic; Masaryk University, Faculty of Science, Department of Chemistry, Centre for Syntheses at Sustainable Conditions and Their Management, University Campus, Kamenice 753/5, CZ-625 00 Brno, Czech Republic. Electronic address: havrankova.e@mail.muni.cz.
245    10
$a Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action / $c E. Havránková, J. Csöllei, D. Vullo, V. Garaj, P. Pazdera, CT. Supuran,
520    9_
$a A new series of s-triazine derivatives incorporating sulfanilamide, homosulfanilamide, 4-aminoethyl-benzenesulfonamide and piperazine or aminoalcohol structural motifs is reported. Molecular docking was exploited to select compounds from virtual combinatorial library for synthesis and subsequent biological evaluation. The compounds were prepared by using step by step nucleophilic substitution of chlorine atoms from cyanuric chloride (2,4,6-trichloro-1,3,5-triazine). The compounds were tested as inhibitors of physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isoforms. Specifically, against the cytosolic hCA I, II and tumor-associated hCA IX. These compounds show appreciable inhibition. hCA I was inhibited with KIs in the range of 8.5-2679.1 nM, hCA II with KIs in the range of 4.8-380.5 nM and hCA IX with KIs in the range of 0.4-307.7 nM. As other similar derivatives, some of the compounds showed good or excellent selectivity ratios for inhibiting hCA IX over hCA II, of 3.5-18.5. 4-[({4-Chloro-6-[(4-hydroxyphenyl)amino]-1,3,5-triazin-2-yl}amino)methyl] benzene sulfonamide demonstrated subnanomolar affinity for hCA IX (0.4 nM) and selectivity (18.50) over the cytosolic isoforms. This series of compounds may be of interest for the development of new, unconventional anticancer drugs targeting hypoxia-induced CA isoforms such as CA IX.
650    _2
$a aminoalkoholy $x chemie $x farmakologie $7 D000605
650    _2
$a antigeny nádorové $x metabolismus $7 D000951
650    _2
$a karboanhydrasa I $x antagonisté a inhibitory $x metabolismus $7 D024401
650    _2
$a karboanhydrasa II $x antagonisté a inhibitory $x metabolismus $7 D024402
650    _2
$a karboanhydrasa IX $x antagonisté a inhibitory $x metabolismus $7 D000071231
650    _2
$a inhibitory karboanhydras $x chemická syntéza $x chemie $x farmakologie $7 D002257
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a piperazin $x chemie $x farmakologie $7 D000077489
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a sulfonamidy $x chemie $x farmakologie $7 D013449
650    _2
$a triaziny $x chemie $x farmakologie $7 D014227
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Csöllei, Jozef $u University of Veterinary and Pharmaceutical Sciences, Faculty of Pharmacy, Department of Chemical Drugs, Palackého 1-3, CZ-612 42 Brno, Czech Republic.
700    1_
$a Vullo, Daniela $u University of Florence, Polo Scientifico, Neurofarba Department, Via Ugo Shiff 6, 500 19 Sesto Fiorentino (Florence), Italy.
700    1_
$a Garaj, Vladimír $u Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Odbojárov 10, 832 32 Bratislava, Slovakia.
700    1_
$a Pazdera, Pavel $u Masaryk University, Faculty of Science, Department of Chemistry, Centre for Syntheses at Sustainable Conditions and Their Management, University Campus, Kamenice 753/5, CZ-625 00 Brno, Czech Republic.
700    1_
$a Supuran, Claudiu T $u University of Florence, Polo Scientifico, Neurofarba Department, Via Ugo Shiff 6, 500 19 Sesto Fiorentino (Florence), Italy. Electronic address: claudiu.supuran@unifi.it.
773    0_
$w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 77, č. - (2018), s. 25-37
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29324250 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190409163110 $b ABA008
999    __
$a ok $b bmc $g 1392230 $s 1051225
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 77 $c - $d 25-37 $e 20180103 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...